Engineers Gate Manager’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Engineers Gate Manager’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-18,335	Closed	-$62K	–	2059
2020 Q2	$62K	Buy	+18,335	New	+$86.7K	﹤0.01%	1624
2019 Q2	–	Sell	-54,321	Closed	-$294K	–	1433
2019 Q1	$294K	Buy	54,321 +23,036	+74%	+$112K	0.02%	747
2018 Q4	$93K	Sell	31,285 -34,985	-53%	-$192K	0.01%	811
2018 Q3	$541K	Buy	66,270 +42,583	+180%	+$327K	0.04%	505
2018 Q2	$231K	Buy	+23,687	New	+$243K	0.02%	744
2017 Q4	–	Sell	-31,465	Closed	-$263K	–	904
2017 Q3	$263K	Buy	+31,465	New	+$333K	0.02%	627

Other funds holding ZYNE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

PCM

Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Engineers Gate Manager's ZYNE Position: Q3 2020 in Review

Engineers Gate Manager sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2020, closing a stake of 18,335 shares — an estimated $62K sold.

Engineers Gate Manager first reported a position in ZYNE in Q3 2017 and held it in 6 quarters. The position peaked at $541K in Q3 2018. 66 funds tracked by Wall St. Rank hold ZYNE as of Q3 2020.

Engineers Gate Manager reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2020 after selling out during the quarter.
Engineers Gate Manager sold 18,335 Zynerba Pharmaceuticals, Inc shares in Q3 2020, an estimated $62K.
Engineers Gate Manager first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2017 and held it in 6 quarters.
Engineers Gate Manager's Zynerba Pharmaceuticals, Inc position peaked at $541K in Q3 2018.
66 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2020.

Based on Engineers Gate Manager's 13F filing for Q3 2020, filed 16 Nov 2020.